Moorthy B
Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA.
J Pharmacol Exp Ther. 2000 Jul;294(1):313-22.
We reported earlier that 3-methylcholanthrene (MC) persistently induces hepatic ethoxyresorufin O-deethylase activities (CYP1A1) in rats for up to 45 days. In this investigation, we tested the hypotheses that persistent expression of CYP1A1 activities is paralleled by sustained induction of CYP1A1/CYP1A2 apoproteins and their mRNAs and that this phenomenon is mediated by mechanisms other than retention of MC in the rat. Rats were given MC (93 micromol/kg) i.p., once daily for 4 days, and CYP1A1/1A2 parameters were measured in liver at selected time points. MC-elicited increases in CYP1A1/1A2 activities, apoprotein contents, and mRNA levels were sustained for several weeks after the last dose of MC treatment. MC also caused long-term induction of CYP1A1 in lungs and mammary glands. Rats treated with [(3)H]MC once daily for 4 days excreted 92. 3% of the administered radioactivity in feces and urine by day 15. The intrahepatic concentration of MC at the 15-day time point was 270 pmol/g. Dose-response studies showed that administration of MC (2 micromol/kg), which produced an intrahepatic concentration of 271 pmol/g after 24 h, did not induce CYP1A1/1A2 activities, strongly suggesting that the sustained induction of CYP1A1/1A2 was not due to retention of the parent MC in the body. Electrophoretic mobility shift assays revealed that persistent CYP1A1 induction by MC involved Ah receptor-independent mechanisms. In conclusion, our results support the hypothesis that persistent expression of CYP1A1/1A2 by MC is mediated by mechanisms independent of the retention of the parent carcinogen.
我们之前报道过,3-甲基胆蒽(MC)可在大鼠体内持续诱导肝乙氧异吩唑酮O-脱乙基酶活性(CYP1A1)长达45天。在本研究中,我们检验了以下假设:CYP1A1活性的持续表达与CYP1A1/CYP1A2载脂蛋白及其mRNA的持续诱导平行,且这种现象是由大鼠体内MC滞留以外的机制介导的。给大鼠腹腔注射MC(93微摩尔/千克),每日一次,共4天,并在选定时间点测量肝脏中的CYP1A1/1A2参数。在最后一次MC治疗剂量后,MC引起的CYP1A1/1A2活性、载脂蛋白含量和mRNA水平的增加持续了数周。MC还导致肺和乳腺中CYP1A1的长期诱导。每天用[³H]MC处理大鼠4天,到第15天时,92.3%的给药放射性通过粪便和尿液排出。第15天时间点肝脏内MC的浓度为270皮摩尔/克。剂量反应研究表明,注射MC(2微摩尔/千克)后24小时肝脏内浓度为271皮摩尔/克,但未诱导CYP1A1/1A2活性,这强烈表明CYP1A1/1A2的持续诱导并非由于母体MC在体内的滞留。电泳迁移率变动分析显示,MC对CYP1A1的持续诱导涉及不依赖芳烃受体的机制。总之,我们的结果支持以下假设:MC对CYP1A1/1A2的持续表达是由独立于母体致癌物滞留的机制介导的。